PE20130612A1 - Tratamiento de enfermedades autoinmunes - Google Patents
Tratamiento de enfermedades autoinmunesInfo
- Publication number
- PE20130612A1 PE20130612A1 PE2012002122A PE2012002122A PE20130612A1 PE 20130612 A1 PE20130612 A1 PE 20130612A1 PE 2012002122 A PE2012002122 A PE 2012002122A PE 2012002122 A PE2012002122 A PE 2012002122A PE 20130612 A1 PE20130612 A1 PE 20130612A1
- Authority
- PE
- Peru
- Prior art keywords
- halogen
- alkyl
- treatment
- benzyloxy
- phenyl
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 BENZYLOXY Chemical class 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 206010025135 lupus erythematosus Diseases 0.000 abstract 1
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE: R1 ES HALOGENO, TRIHALOGENOMETILO, OH, ALQUILO C1-C7, TRIFLUOROMETOXI, ENTRE OTROS; R2 ES H, HALOGENO, ALCOXI C1-C4, FENETILO, BENCILOXI, ENTRE OTROS; R3 ES H, HALOGENO, CF3, ALQUILO C1-C7, FENILO, ENTRE OTROS; R4 Y R5 SON CADA UNO H , UN RESIDUO DE FORMULA (a); R8 Y R9 SON CADA UNO H O ALQUILO C1-C4 OPCIONALMENTE SUSTITUIDO POR HALOGENO; n ES UN ENTERO DE 1 - 4; X ES O, SO, S, SO2. SON COMPUESTOS PREFERIDOS: 2-AMINO-2-[4-(3-BENCILOXIFENILTIO)-2-CLOROFENIL] ETIL-PROPANO-1,3-DIOL; ESTER MONO-{(S)-2-AMINO-4-[4-(3-BENCILOXI-FENILSULFANIL)-2-CLORO-FENIL]-2-HIDROXIMETIL-BUTILICO} DEL ACIDO FOSFORICO; ENTRE OTROS. DICHO COMPUESTO ES UN INMUNOSUPRESOR BIEN TOLERADO Y CON UN PERFIL DE SEGURIDAD FAVORABLE UTIL EN EL TRATAMIENTO DE LUPUS ERITEMATOSO SUBCUTANEO AGUDO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10162079 | 2010-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20130612A1 true PE20130612A1 (es) | 2013-06-06 |
Family
ID=42199281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2012002122A PE20130612A1 (es) | 2010-05-06 | 2011-05-05 | Tratamiento de enfermedades autoinmunes |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20130172297A1 (es) |
| EP (1) | EP2566470A1 (es) |
| JP (1) | JP2013530937A (es) |
| KR (1) | KR20130066630A (es) |
| CN (1) | CN102869353A (es) |
| AU (1) | AU2011249784B2 (es) |
| BR (1) | BR112012028190A2 (es) |
| CA (1) | CA2795394A1 (es) |
| CL (1) | CL2012003091A1 (es) |
| CR (1) | CR20120566A (es) |
| CU (1) | CU20120154A7 (es) |
| EA (1) | EA201201514A1 (es) |
| EC (1) | ECSP12012312A (es) |
| IL (1) | IL222690A0 (es) |
| MA (1) | MA34285B1 (es) |
| MX (1) | MX2012012926A (es) |
| NZ (1) | NZ603999A (es) |
| PE (1) | PE20130612A1 (es) |
| PH (1) | PH12012502418A1 (es) |
| SG (1) | SG185746A1 (es) |
| TN (1) | TN2012000509A1 (es) |
| TW (1) | TW201201814A (es) |
| WO (1) | WO2011138393A1 (es) |
| ZA (1) | ZA201207710B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI519539B (zh) | 2010-12-21 | 2016-02-01 | Kyorin Seiyaku Kk | Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof |
| US9289494B2 (en) | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1431284E (pt) | 2001-09-27 | 2008-01-21 | Kyorin Seiyaku Kk | Derivado de sulfureto de diarilo, um seu sal de adição e imunossupressor |
| US6963012B2 (en) * | 2001-09-27 | 2005-11-08 | Kyorin Pharmaceutical Co., Ltd. | Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| EP1548003A4 (en) | 2002-09-19 | 2006-06-07 | Kyorin Seiyaku Kk | AMINO ALCOHOL DERIVATIVE, ADDITIONAL SALT AND IMMUNOSUPPRESIVE AGENT |
| CA2515574C (en) * | 2003-02-18 | 2012-03-13 | Kyorin Pharmaceutical Co., Ltd. | Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor |
| EP1628957B1 (en) * | 2003-05-26 | 2010-09-29 | Takeda Pharmaceutical Company Limited | Sulfopyrroles |
| US7528120B2 (en) | 2003-08-28 | 2009-05-05 | Novartis Ag | Aminopropanol derivatives |
| EP1723138B1 (en) * | 2004-02-11 | 2010-07-14 | Basilea Pharmaceutica AG | Substituted benzimidazoles and their use for inducing apoptosis |
| JPWO2006041015A1 (ja) * | 2004-10-12 | 2008-05-15 | 杏林製薬株式会社 | アミノアルコール誘導体とその付加塩及び免疫抑制剤 |
| GB0504544D0 (en) * | 2005-03-04 | 2005-04-13 | Novartis Ag | Organic compounds |
| SG165364A1 (en) * | 2005-09-09 | 2010-10-28 | Novartis Ag | Treatment of autoimmune diseases |
-
2011
- 2011-05-05 US US13/643,320 patent/US20130172297A1/en not_active Abandoned
- 2011-05-05 EP EP11723889A patent/EP2566470A1/en not_active Withdrawn
- 2011-05-05 KR KR1020127031868A patent/KR20130066630A/ko not_active Withdrawn
- 2011-05-05 SG SG2012086526A patent/SG185746A1/en unknown
- 2011-05-05 AU AU2011249784A patent/AU2011249784B2/en not_active Ceased
- 2011-05-05 WO PCT/EP2011/057203 patent/WO2011138393A1/en not_active Ceased
- 2011-05-05 NZ NZ603999A patent/NZ603999A/en not_active IP Right Cessation
- 2011-05-05 BR BR112012028190A patent/BR112012028190A2/pt not_active IP Right Cessation
- 2011-05-05 CN CN2011800224469A patent/CN102869353A/zh active Pending
- 2011-05-05 PE PE2012002122A patent/PE20130612A1/es not_active Application Discontinuation
- 2011-05-05 MX MX2012012926A patent/MX2012012926A/es not_active Application Discontinuation
- 2011-05-05 PH PH1/2012/502418A patent/PH12012502418A1/en unknown
- 2011-05-05 CA CA2795394A patent/CA2795394A1/en not_active Abandoned
- 2011-05-05 TW TW100115816A patent/TW201201814A/zh unknown
- 2011-05-05 MA MA35416A patent/MA34285B1/fr unknown
- 2011-05-05 EA EA201201514A patent/EA201201514A1/ru unknown
- 2011-05-05 JP JP2013508502A patent/JP2013530937A/ja active Pending
-
2012
- 2012-10-15 ZA ZA2012/07710A patent/ZA201207710B/en unknown
- 2012-10-23 TN TNP2012000509A patent/TN2012000509A1/en unknown
- 2012-10-25 IL IL222690A patent/IL222690A0/en unknown
- 2012-11-05 CU CU2012000154A patent/CU20120154A7/es unknown
- 2012-11-06 CL CL2012003091A patent/CL2012003091A1/es unknown
- 2012-11-06 CR CR20120566A patent/CR20120566A/es unknown
- 2012-11-27 EC ECSP12012312 patent/ECSP12012312A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013530937A (ja) | 2013-08-01 |
| TW201201814A (en) | 2012-01-16 |
| ZA201207710B (en) | 2013-06-26 |
| EA201201514A1 (ru) | 2013-05-30 |
| AU2011249784B2 (en) | 2014-03-06 |
| IL222690A0 (en) | 2012-12-31 |
| CA2795394A1 (en) | 2011-11-10 |
| ECSP12012312A (es) | 2012-12-28 |
| BR112012028190A2 (pt) | 2016-08-02 |
| CR20120566A (es) | 2013-01-09 |
| TN2012000509A1 (en) | 2014-04-01 |
| KR20130066630A (ko) | 2013-06-20 |
| WO2011138393A1 (en) | 2011-11-10 |
| PH12012502418A1 (en) | 2018-03-21 |
| SG185746A1 (en) | 2013-01-30 |
| US20130172297A1 (en) | 2013-07-04 |
| AU2011249784A1 (en) | 2012-12-20 |
| MX2012012926A (es) | 2012-12-17 |
| CL2012003091A1 (es) | 2013-03-22 |
| MA34285B1 (fr) | 2013-06-01 |
| CN102869353A (zh) | 2013-01-09 |
| CU20120154A7 (es) | 2013-03-27 |
| NZ603999A (en) | 2014-06-27 |
| EP2566470A1 (en) | 2013-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091407A1 (es) | Antagonistas de aminoalquilbifenilo n,n-disubstituidos de receptores de prostaglandina d2 | |
| MX2017006382A (es) | Analogos de eter fosfolipidico como portadores de farmacos dirigidos a cancer. | |
| MX2020010330A (es) | Proceso para preparar un compuesto antiviral de formula i. | |
| CO6852080A2 (es) | Compuestos para el tratamiento y profilaxis de la enfermedad del virus sincital repiratorio | |
| CR20160119A (es) | Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística | |
| NI201300025A (es) | Agente de control de plagas | |
| CR20130129A (es) | Anàlogos de buprenorfina | |
| AR087538A1 (es) | Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-alcoxi-2-alquinil/alquenil-etil}-1h-[1,2,4]triazol sustituidos | |
| MA35089B1 (fr) | Inhibiteurs de la production de leucotrienes de type benzodioxane | |
| PE20142110A1 (es) | Proceso de tratamiento con amina para la separacion selectiva de gas acido | |
| GT201400289A (es) | "compuestos de acido dimetil-benzoico" | |
| EA201690879A1 (ru) | Новое триазолопиридиновое соединение | |
| BR112014016048A8 (pt) | métodos de formação de ésteres de pinacol do ácido 4-cloro-2-fluoro-3-fenilborônico substituído e métodos de usar os mesmos | |
| MX343611B (es) | Composicion de control de fitoenfermedades y su uso. | |
| PE20141201A1 (es) | Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv) | |
| PE20142445A1 (es) | Compuestos de pirazol sustituidos como antagonistas de lpar | |
| BR112016018851A8 (pt) | processo para fornecer um composto de fórmula (iv) | |
| BR112013028486A2 (pt) | método para promover crescimento de planta | |
| PE20151139A1 (es) | Pirrolopirazoles como bloqueadores del canal de calcio tipo n | |
| PE20130612A1 (es) | Tratamiento de enfermedades autoinmunes | |
| UA107831C2 (en) | Composition for combating plant diseases and its application | |
| AR093977A1 (es) | Proceso para la preparacion de 4-amino-5-fluoro-3-cloro-6-picolinatos (sustituidos) | |
| AR088358A1 (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos | |
| AR074230A1 (es) | Proceso para preparar acido zoledronico | |
| BR112015000012A2 (pt) | composto de fórmula (i), e quantidade eficaz do composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |